Advertisement

Topics

Glycosynth Limited Company Profile

08:36 EDT 19th September 2018 | BioPortfolio

Glycosynth is a specialist manufacturer of enzyme substrates accredited to ISO 9001:2000 standards. Our products find wide applications in clinical, food and environmental microbiology, plant molecular biology, and general diagnostics.
We offer a range of 4-Methylumbelliferyl [4MU], Nitrophenyl, 7-Amido-4-methylcoumarin [AMC], Indolyl, Naphthyl and other substrates as well as a new range of patented products. Please select from the groups below, or use our search facility for specific items or interests. Full details, including packs, prices and application references, can then be found by selecting the product of interest.

Location

14 Craven Court, Winwick Quay
Warrington
Cheshire
WA2 8QU
United Kingdom

Contact

Phone: 44 (0) 1925 575075
Fax: 44 (0) 1925 575121
Email: info@glycosynth.co.uk


News Articles [27 Associated News Articles listed on BioPortfolio]

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited

VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has...

Quotient Limited Reports Concordance Data from the MosaiQ European Field Trial

Field trial concordance data exceed targeted criteriaPlanned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QT...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [84 Associated Companies listed on BioPortfolio]

Glycosynth Limited

Glycosynth is a specialist manufacturer of enzyme substrates accredited to ISO 9001:2000 standards. Our products find wide applications in clinical, food and environmental microbiology, plant molecula...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Glycosynth Limited" on BioPortfolio

We have published hundreds of Glycosynth Limited news stories on BioPortfolio along with dozens of Glycosynth Limited Clinical Trials and PubMed Articles about Glycosynth Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glycosynth Limited Companies in our database. You can also find out about relevant Glycosynth Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record